Boehringer Ingelheim Recognized for Tenth Consecutive Year on Science Magazine’s 2014 Top Employers List

Ridgefield, Conn., October 17, 2014 – Boehringer Ingelheim announced today that it has been recognized by Science magazine for the tenth consecutive year as a top company to work for in the pharmaceutical and biotechnology industries. The company was ranked 13 out of 20, demonstrating its exceptional reputation.

“We are honored to be named for the tenth year in a row on Science magazine’s Top Employers list,” said Dr. James Baxter, Senior Vice President of Development at Boehringer Ingelheim. “This recognition speaks to the company’s commitment to providing our employees with a healthy work-life balance, a positive corporate environment, and diversity in all aspects of our business. It is important for our employees to feel rewarded for their work, as they play a key role in our accomplishments and continuing to bring new medicines to patients.”

Boehringer Ingelheim believes that a strong corporate culture is deeply rooted in its success and is committed to nurturing relationships with its patients, customers, communities and employees.

Science magazine’s annual survey polls employees in the biotechnology, biopharmaceutical and pharmaceutical industries. Respondents are asked to rate companies based on 23 characteristics, including corporate image, financial prowess, leadership and direction, work culture/environment, location, and academic and intellectual challenge.

This recognition follows the recent news that Boehringer Ingelheim was named to Working Mother’s 100 Best Companies list.

For the complete feature along with individual company rankings, go to
www.sciencecareers.org/TopEmployers2014.

About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, Conn., is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.

In 2013, Boehringer Ingelheim achieved net sales of about $18.7 billion (14.1 billion euro). R&D expenditure in the Prescription Medicines business corresponds to 19.5% of its net sales.

For more information please visit http://www.us.boehringer-ingelheim.com